Papers
3
Total Citations
83
H-Index
2
About
Dr. Christine Gaspard is a leading urologic surgeon and researcher whose work is revolutionizing the surgical management of genitourinary cancers. Her primary research focus is the application of robotic-assisted surgery for complex oncologic procedures, specifically targeting renal cell carcinoma and testicular cancer. Dr. Gaspard’s major contributions include two landmark systematic reviews and meta-analyses. Her 2022 study on robotic-assisted radical nephrectomy with inferior vena cava thrombectomy (51 citations) provided critical evidence on the safety and feasibility of this minimally invasive approach, demonstrating comparable or superior perioperative outcomes to traditional open surgery. She has similarly advanced the field of testicular cancer care through her comprehensive analyses of robot-assisted retroperitoneal lymph node dissection (R-RPLND), with her 2023 review (31 citations) establishing R-RPLND as a viable, less invasive alternative to open surgery. By synthesizing global data, Dr. Gaspard has provided the highest level of evidence to guide clinical practice, helping to reduce recovery times and complications for patients facing these challenging diagnoses. Her work is instrumental in defining the next standard of care in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3